[Neuroimaging in Lyme disease]

Andrzej Ustymowicz1

  • 1Kliniki Chorób zakaźnych i Neuroiniekcji AM w Białymstoku. ambau@yahoo.com

Insights

Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) reveal abnormalities in neuroborreliosis patients, aiding central nervous system disorder diagnostics.

Area of Science:

  • Neuroimaging
  • Neurology
  • Infectious Diseases

Context:

  • Central nervous system (CNS) disorders require accurate diagnostic tools.
  • Neuroborreliosis is a CNS manifestation of Lyme disease, often presenting with subtle or varied symptoms.
  • Advanced imaging is crucial for understanding the pathophysiology and extent of CNS involvement.

Purpose:

  • To describe the characteristic abnormalities detected by Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in patients diagnosed with neuroborreliosis.
  • To correlate imaging findings with clinical presentation and disease progression.
  • To evaluate the utility of MRI and MRS as diagnostic aids for neuroborreliosis.

Summary:

  • MRI demonstrates various CNS abnormalities in neuroborreliosis, including leptomeningeal enhancement, focal lesions, and cranial nerve abnormalities.
  • MRS reveals metabolic changes in affected brain regions, potentially indicating inflammation or tissue damage.
  • These imaging findings contribute to the diagnosis and characterization of central nervous system involvement in Lyme disease.

Impact:

  • Highlights the role of advanced neuroimaging in diagnosing neuroborreliosis.
  • Provides a basis for further research into the specific imaging biomarkers of CNS Lyme disease.
  • Aids clinicians in interpreting imaging studies for patients with suspected neuroborreliosis.

Related Concept Videos